Here are our highlights from day 3 of the NCRI Cancer Conference, including personalised treatment for prostate cancer, and new surgery tech.
On Ada Lovelace Day 2016, we speak to Dr Bissan Al-Lazikani about how she is using computers to help personalise cancer treatment.
Last month’s 2016 MAP conference showcased progress so far on personalised cancer treatment, and discussed future challenges.
Our scientists have developed a new, more accurate way to test hundreds of cancer drugs at the same time.
Scientists have discovered that oesophageal cancer can be classified into three different subtypes, paving the way for testing targeted treatments.
Our scientists have revealed how a targeted skin cancer drug works, which could help tackle drug resistance.
Brain tumours are one of the biggest challenges in cancer research, but we have a plan to tackle them.
We investigate organoids, the latest way that scientists are growing cancer cells in the lab to help test hundreds of cancer drugs.
Advanced imaging technology is helping our scientists understand how key molecules fuel the growth of breast cancer cells.
Inherited gene faults are more common among men with advanced prostate cancer than in those with localised disease.